The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To DebutBenzinga via Yahoo FinanceMay 09 11:56 AM
The biotech company developing therapies and food to treat metabolic dysregulation in the liver is to list its shares on the Nasdaq under the ticker symbol AXLA. Cortexyme, which develops a ...
Pain Management Market by Indication, Application Devices and Drugs, Industry Share with Competitive Landscapes and Trends 2019, Forecast 2023Market Watch2 days ago
- Market Watch2 days ago
Post-Operative Pain Management Market to Expand Steadily At A CAGR Of 5.4% during 2019-2023 | Says MRFRMarket Watch2 days ago